Background: Rat skin and goat cul de sac are mostly used in optimization of formulations as the model of human skin and cul de sac. Aim: To explore the correlation between lipid content of rat skin and goat cul de sac and permeability. Materials and methods: Find out wavelength maximum for Sapat plus malam®, Ciplox eye ointment® and chloramphenicol eye caps and the standard curve was also derived. In vitro studies using Cellophane® membrane and ex vivo studies using rat skin or goat cul de sac of the formulations. Permeability coeffi cient, % dislodgeable dose, lag time, diff usion parameter, and partition coeffi cient were found for both studies after six and a half hours of penetration studies. Student's unpaired t-test with equal variance was used to fi nd any statistically signifi cant diff erence in the ex vivo and in vitro diff usion transport studies at 95% level of confi dence. Results: Permeability coeffi cient of Sapat plus malam®, Ciplox eye ointment® and chloramphenicol eye caps were 0.000316 ± 0.0000625, 0.00416 ± 0.0001, 0.0034 ± 0.00004 for Cellophane® membrane and 0.0001 ± 0.000001, 0.002254 ± 0.0002, 0.00303 ± 0.0001 for ex vivo membrane in cm 2 /min, respectively. For all three formulations, there were calculated t values which were higher than tabulated t values at 95% of confi dence level (P<0.05). Conclusion: Cellophane® membrane shows a better diff usion than rat skin or goat cul de sac. In the optimization of formulation, only Cellophane® membrane is advisable to use.
Most of the drugs delivered across topical or ocular route are effectively affected by lipid content of stratum corneum and conjunctiva respectively. Various membranes are used for ex vivo studies because human skin and eye are diffi cult to acquire due to ethical issues. The model Cellophane ® membrane is the most commonly used among model membranes because of its nature. It is made of pure cellulose and it is free from fat content. Therefore, there could be no interference of lipid content during the drug penetration. For topical preparation rat skin and for ophthalmic preparation ocular goat cul de sac are also used because rat and goat are most freely available animals and they are easy to handle as well. 1, 2 In the present study, a comparison was made of the permeability of well-known Indian market brands Sapat plus malam ® , Ciplox eye ointment ® and chloramphenicol eye caps in Cellophane ® membrane and permeability through rat skin and goat cul de sac, respectively. The study concluded that there was a strong negative monotonic correlation between membrane lipid content and formulation's permeability.
AIM
The aim of this study was to explore the correlation between lipid proportion of rat skin and goat cul de sac and drug permeability.
MATERIALS AND METHODS
Sapat plus malam ® , Ciplox eye ointment ® and chloramphenicol eye caps were purchased from Sapat and Co. Pvt. Ltd, Mumbai, India, Cipla Ltd, Mumbai, India and Jyoti capsules, Kanpur, India, respectively. Cellophane ® membrane was purchased from Angle trading, Rajkot, India. Methanol, sodium chloride, sodium hydroxide and potassium dihydrogen phosphate were purchased from Oxford lab, Mumbai, India. Rat skin was procured from the animal house, School of Pharmacy, RK University, Rajkot, India. Goat eye were delivered from a local slaughterhouse for human feeding.
PRELIMINARY STUDIES 100 mg of Sapat plus malam ® were soaked in 100 mL phosphate buffer pH 6.8 overnight. 100 mg of Ciplox eye ointment ® and chloramphenicol eye caps were soaked in 100 mL methanol/ phosphate buffer (25:75% v/v) pH 6.8 and pH 7.4 overnight, respectively. Then they were fi ltered through fi lter paper of 11 μm pore size. The fi ltrate was scanned in 200-400 nm by Double Beam UV-visible Spectrophotometer (LT-2900, Labtronics (I) Pvt. Ltd., Ambala, India). The wavelength at which absorbance was maximal was considered as wavelength maximum for the prospective study. Standard curve was also derived at wavelength maximum. 3 ORGANOLEPTIC ASSESSMENT AND PH VALUE Particular organoleptic features of the formulations like appearance, homogeneity, texture were measured visually while pH of the formulations was measured by digital pH meter (335, Systronics, Ahmedabad, India). 4 
IN VITRO DIFFUSION STUDY
This study was performed by Franz diffusion cell (Durasil ® (I) Pvt. Ltd; 3.14 cm 2 of effective diffusion area and 20 mL of receiver chamber capacity) using Cellophane ® membrane. Cellophane ® membrane was heated in 0.1N NaOH for half an hour to make it semipermeable having the pore size of 80 μm. It was mounted between the receiver and donor compartments of the cell. 5 Initially, the receiver compartment was fi lled with phosphate buffer pH 6.8, methanol/phosphate buffer pH 6.8 and methanol/phosphate buffer pH 7.4 for Sapat plus malam ® , Ciplox eye ointment ® and chloramphenicol eye caps (25:75% v/v), respectively and the donor chamber was empty. The receiver buffer was stirred at a speed of 150 rpm and assembled the apparatus on a magnetic stirrer with the hot plate (2MLH, Remi equipment, India) at 37 ± 1°C temperature. Aliquots were withdrawn at regular time intervals and analyzed for drug content by UV spectrophotometry. 4, 6, 7 EX VIVO DIFFUSION STUDIES This study was performed with the same Franz diffusion cell in the same manner but using abdominal rat skin and cul de sac of goat as membrane respectively. 8 The skin was extracted from the abdominal region of the rat. It was wiped with methanol and washed with tap water to remove adhering materials. It was mounted in between the two compartments of the Franz diffusion cell, so as the stratum corneum side was towards the donor chamber. Freshly excised goat ocular membrane was procured from local goat slaughterhouse for human feeding to laboratory in cold (2°C) 0.9% w/v saline within 3 h of slaughtering. No goat was separately killed for the study. The corneas were carefully dissected along with 4 cm 2 of the area, sclera tissue from the eyeball and washed with tap water to remove any adhering materials. It was mounted between the two chambers of the cell where the conjunctiva side was towards the donor chamber. 9 The whole study was approved by the Institutional Animal Ethics Committee (IAEC), New Delhi, India, under the reference number RKCP/COL/RP/16/74. 10 
PERMEATION DATA ANALYSIS
The cumulative amount of drug permeated through the membrane (mg/cm 2 ) against time curve was plotted for each formulation. The drug fl ux was found by dividing the slope of the graph linear portion with the effective diffusion cell area (mg/ cm 2 min). The permeability coeffi cient was derived by dividing drug fl ux by the initial concentration of the drug in the donor chamber. The lag time, i.e. the time at which drug release from formulation was also determined by extrapolating the curve to the abscissa. 11 The diffusion parameter was found from lag time by 6 1 (lag time). The time required for the release of more than 90 percentages of the drug (t 90 ) and to achieve MIC value (t MIC ) were noted. Drugs are targeted for local action, so t 90 and t MIC for ex vivo dynamics studies were not evaluated. 6, 12 The remaining of the formulation on the membrane (dislodgeable dose) was put in a 100-mL glass beaker. The membrane and the used spatula were washed fi ve times with respective phosphate buffer. The fi nal volume was made to 10 mL with the same and the mixture was stirred (1000 rpm) for 1 h. One mL of it was transferred to a 10 mL volumetric fl ask and volume was adjusted with the same. The resulting solution was fi ltered through fi lter paper and the remaining amount of drug was quantifi ed by the spectrometric method. 13 Partition coeffi cients were derived by the ratio of dislodgeable dose to permeable dose. Local accumulation (LAC) was derived by the ratio of drug retained in the membrane to the drug that penetrated. 14 
IN VITRO DRUG RELEASE KINETIC STUDY
Data treatment for all the formulations was done using the following models: zero-order kinetic, fi rst-order kinetic, Higuchi, Korsmeyer/Peppa's, Hixson Crowell, Weibull, and Baker-Lonsdale. The equation of plot, correlation coeffi cient (R 2 ) value, slope of the plot, and sum of square residual was found. The model with the smallest sum of squared residual value was selected as best fi t. 7, 15 STATISTICAL ANALYSIS Student's unpaired t-test with equal variance was used to fi nd any statistically signifi cant difference in the in vitro and ex vivo diffusion transport studies at 95% level of confi dence. 12, 16 All data were given as mean ± SD from fi ve independent experiments.
RESULTS
Sapat plus malam ® showed wavelength maximum at 295 nm in phosphate buffer pH 6.8, Ciplox eye ointment ® and chloramphenicol eye caps showed wavelength maximum at 286 nm and 274 nm in methanol/phosphate buffer (25:75% v/v) pH 6.8 and 7.4, respectively. The calibration curves showed linearity in 8-50 μg/mL concentration (R 2 ≥0.98). Permeation data showed better values for Cellophane ® membrane than ex vivo studies ( Table 1) . After 6 and a half hours, there was more permeation of drug through Cellophane ® membrane than ex vivo studies (Fig. 1) . Permeability coeffi cients for Cellophane ® membrane were higher than ex vivo studies (Fig. 2) . Sapat plus malam ® , Ciplox eye ointment ® , and chloramphenicol eye caps had the minimum sum of square values in 0.73, 0.009, and 0.013 in Korsmeyer/Peppa's (0.45< release exponent = 0.4708 <0.89), fi rst order, and Hixson Crowell model, respectively. For Sapat plus malam ® , the calculated t value was 3.26, tabulated t value was 2.06 (pooled degree of freedom was 24), for Ciplox eye ointment ® , calculated t value was 2.23, tabulated t value was 2.18 (pooled degree of freedom was 12) and for chloramphenicol eye caps, calculated t values was 2.41, tabulated t value was 2.06 (pooled degree of freedom was 24). In all three formulations, calculated t values were higher than tabulated t values, P<0.05, which was signifi cant at 95% level of signifi cance.
DISCUSSION
In vitro drug release profi le of Sapat plus malam ® , Ciplox eye ointment ® , and chloramphenicol eye caps followed Korsmeyer/Peppa's (Non-Fickian transport), fi rst order, and Hixson Crowell model, respectively. 17 Studies demonstrated that cumulative drug release was higher for in vitro studies than ex vivo studies, Cellophane ® membrane had more diffusion, higher permeability coeffi cient, lower lag time, less drug accumulation, less dislodgeable dose, less diffusion parameter and less partition coeffi cient than rat skin or goat cul de sac. This was so because lipid content of the rat skin or goat cul de sac interferes with the permeation of drug and decreases its permeability. 18 There was also one reason that in formulations there was only white soft paraffi n as the base no penetration enhancers were used. White soft paraffi n is unable to break the lipid-lipid and lipid-protein bond of skin so there was less permeability of drug and high dislodgeable dose. There was no correlation between permeability coeffi cient of Cellophane ® and that of rat skin or goat cul de sac. 19, 20 Permeability coeffi cient of Sapat plus malam ® , Ciplox eye ointment ® had vast difference compared to that of chloramphenicol eye caps among in vitro and ex vivo studies. This is due to the fact that rat skin has higher lipid content than goat cul de sac.
CONCLUSION
Present investigation of the effect of permeation using different membranes for well-established brands in India concluded that researchers should not use rat skin or goat cul de sac for their optimization of the formulation. This is because of the following two reasons: each time the fat content of rat skin and goat cul de sac was found to be varying. Presence or absence of permeation enhancer(s) in the formulation. Therefore, misleading results will be obtained as compared to Cellophane ® membrane. Moreover, Cellophane ® membrane is more suitable to be used for the development of formulations as it has no lipid content. 
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